CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
-7.95%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$252M
AUM Growth
-$77.3M
(-23%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
81.4%
Holding
29
New
4
Increased
8
Reduced
8
Closed
3
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$13.2M |
| 2 |
Mineralys Therapeutics
MLYS
|
$5.41M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$4.66M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$4.63M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$3.42M |
Top Sells
| 1 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$46.9M |
| 2 |
Disc Medicine
IRON
|
$4.7M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$4.08M |
| 4 |
Direxion Daily S&P Biotech Bear 3X Shares
LABD
|
$2.06M |
| 5 |
Pliant Therapeutics
PLRX
|
$1.78M |
Sector Composition
| 1 | Healthcare | 98.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Precision BioSciences
DTIL
$59.3M
| $207K | 0.08% |
20,221
-33,231
| -62% | -$340K |
|
|
HOOK
27
DELISTED
HOOKIPA Pharma
HOOK
| – | – |
-78,874
| Closed | -$694K |
|
|
VECT
28
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| – | – |
-2,782,756
| Closed | -$46.9M |
|
29
Corvus Pharmaceuticals
CRVS
$434M
| – | – |
-200,000
| Closed | -$458K |
|